Cover Image

Editorial: IBD Management-Novel Targets and Therapeutic Perspectives

Saved in:

Bibliographic Details
Main Authors:	Luca Antonioli (Author), Matteo Fornai (Author), Barbara Romano (Author), Carolina Pellegrini (Author), Corrado Blandizzi (Author)
Format:	Book
Published:	Frontiers Media S.A., 2020-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Managing Obesity and Related Comorbidities: A Potential Pharmacological Target in the Adenosine System?
by: Vanessa D'Antongiovanni, et al.
Published: (2021)

IBD Management - Novel Targets and Therapeutic Perspectives
Published: (2020)

Purinergic Ligands as Potential Therapeutic Tools for the Treatment of Inflammation-Related Intestinal Diseases
by: Diego Dal Ben, et al.
Published: (2018)

Targeting microbial pathogenic mechanisms as a novel therapeutic strategy in IBD
by: Paul F. Miller
Published: (2024)

Hsp60 as a Novel Target in IBD Management: A Prospect
by: Francesco Cappello, et al.
Published: (2019)

Donepezil improves vascular function in a mouse model of Alzheimer's disease
by: Carolina Pellegrini, et al.
Published: (2021)

Oligonucleotides-A Novel Promising Therapeutic Option for IBD
by: Patrizio Scarozza, et al.
Published: (2019)

Pathophysiology of NSAID-Associated Intestinal Lesions in the Rat: Luminal Bacteria and Mucosal Inflammation as Targets for Prevention
by: Rocchina Colucci, et al.
Published: (2018)

A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation
by: Carolina Pellegrini, et al.
Published: (2018)

Editorial: Microbiome in IBD: From Composition to Therapy
by: Ruixin Zhu, et al.
Published: (2021)

The Function of Necroptosis and Its Treatment Target in IBD
by: Francis Atim Akanyibah, et al.
Published: (2024)

Editorial: Neurological, Metabolic and Inflammatory Disorders: A Common Root in Inflammasome
by: Carolina Pellegrini, et al.
Published: (2021)

Editorial: Microbiome in IBD: From Composition to Therapy, Volume II
by: Ning-Ning Liu, et al.
Published: (2023)

Targeting the Eph/Ephrin System as Anti-Inflammatory Strategy in IBD
by: Andrea Grandi, et al.
Published: (2019)

Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity
by: Daniela Gentile, et al.
Published: (2018)

Latest Treatment Perspectives for IBD-related Arthritis - a review
by: Michał Sęk, et al.
Published: (2024)

Treatment goals in IBD: A perspective from patients and their partners
by: Niene M.S. Peek-Kuijt, et al.
Published: (2022)

Current Role of Monoclonal Antibody Therapy in Pediatric IBD: A Special Focus on Therapeutic Drug Monitoring and Treat-to-Target Strategies
by: Merle Claßen, et al.
Published: (2023)

Live Typhoid Vaccine for IBD-Patients-Well Tolerated and with Possible Therapeutic Effect
by: Arnold Berstad, et al.
Published: (2008)

Live Typhoid Vaccine for IBD-Patients--Well Tolerated and with Possible Therapeutic Effect
by: Gunnar Nysæter Dr, et al.
Published: (2008)

Live Typhoid Vaccine for IBD-Patients—Well Tolerated and with Possible Therapeutic Effect
by: Gunnar Nysæter, et al.
Published: (2008)

Editorial: Novel Therapeutic Targets and Emerging Treatments for Fibrosis
by: Chrishan S. Samuel, et al.
Published: (2017)

Colon targeting in rats, dogs and IBD patients with species-independent film coatings
by: F. Ferraro, et al.
Published: (2024)

Editorial: Molecular pathways and novel therapeutic targets in regenerative dentistry
by: Bruno Cavalcanti, et al.
Published: (2024)

Editorial: Novel therapeutic approaches to target drug resistant tumors
by: Chiara Riganti, et al.
Published: (2023)

Editorial: Novel therapeutic target and drug discovery for neurological diseases
by: Kaiyue Zhao, et al.
Published: (2022)

Health Literacy of Children and Adolescents with Inflammatory Bowel Disease (IBD) and Parents of IBD Patients-Coping and Information Needs
by: Kalina Kaul, et al.
Published: (2024)

Nutrition in Inflammatory Bowel Disease (IBD)
by: Raman, Maitreyi
Published: (2019)

Gut-directed therapy in Parkinson's disease
by: Laura Benvenuti, et al.
Published: (2024)

Is There a Risk of Lymphoma Associated With Anti-tumor Necrosis Factor Drugs in Patients With Inflammatory Bowel Disease? A Systematic Review of Observational Studies
by: Sara Ferraro, et al.
Published: (2019)

JAK inhibitors: an evidence-based choice of the most appropriate molecule
by: Luca Antonioli, et al.
Published: (2024)

Editorial: Ferroptosis as a novel therapeutic target for inflammation-related diseases
by: Yongyi Liang, et al.
Published: (2023)

Editorial: Novel Therapeutic Target and Drug Development in Neurovascular Retinal Diseases
by: Zhuo Shao, et al.
Published: (2021)

Editorial: Recent advances in novel therapeutic molecules and targets for inflammatory diseases
by: Feng Li, et al.
Published: (2023)

Editorial: Neonatal and pediatric brain injury: novel therapeutics and perspective
by: Takeo Mukai, et al.
Published: (2023)

POSSIBLE ADVERSE EVENTS DURING IBD TREATMENT.
by: Adriana Krasteva, et al.
Published: (2011)

Assessment of Growth Disturbance in Japanese Children with IBD
by: Tetsuo Shono, et al.
Published: (2010)

Prognostic Factors of Biologic Therapy in Pediatric IBD
by: Anna Buczyńska, et al.
Published: (2022)

Intestinal Immune Imbalance is an Alarm in the Development of IBD
by: Chunli Hu, et al.
Published: (2023)

Editorial: Peptidases as a therapeutic target in anti-cancer management
by: Ana Mitrović, et al.
Published: (2024)